M. D. Anderson Cancer Center
UniversityÃ‚Â ofÃ‚Â Texas, Houston, TX, USA
Elias Jabbour joined the University of Texas M. D. Anderson Cancer in 2003 as a fellow in the Department of Hematology/Leukemia and Stem cell. Thereafter, in 2007, he joined the faculty in the Leukemia department as Assistant Professor. Dr. Jabbour has taken an active role in the medical community, participating in numerous scientific meetings. He has authored or co-authored more than 100 medical publications and abstracts and serves as a reviewer numerous scientific journals. In 2005, 2006, and 2007, he received the ASCO and the ASH merit awards for Outstanding Clinical fellow.
Dr. Jabbour is actively involved in research in both acute and chronic forms of leukemia. He was actively involved in clinical trials that lead to the approval of several drugs in chronic myeloid leukemia (CML) and myelodysplastic syndromes. His research on resistance to imatinib and mutations of the protein kinase domain were presented in several international; meetings and published in peer-reviewed journals. He is also developing tailored therapies to CML.